Does PEMBROLIZUMAB Cause Hepatitis? 935 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 935 reports of Hepatitis have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 1.1% of all adverse event reports for PEMBROLIZUMAB.
935
Reports of Hepatitis with PEMBROLIZUMAB
1.1%
of all PEMBROLIZUMAB reports
167
Deaths
431
Hospitalizations
How Dangerous Is Hepatitis From PEMBROLIZUMAB?
Of the 935 reports, 167 (17.9%) resulted in death, 431 (46.1%) required hospitalization, and 79 (8.4%) were considered life-threatening.
Is Hepatitis Listed in the Official Label?
Yes, Hepatitis is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Hepatitis?
METHOTREXATE (1,835)
ACETAMINOPHEN (1,450)
TOCILIZUMAB (1,184)
HYDROXYCHLOROQUINE (1,133)
ADALIMUMAB (1,096)
RITUXIMAB (1,017)
ETANERCEPT (1,013)
LEFLUNOMIDE (997)
NIVOLUMAB (930)
ABATACEPT (902)
Which PEMBROLIZUMAB Alternatives Have Lower Hepatitis Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G